News
Business
Economy
Politics
Technology
Environment
Search
Saturday, November 16, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
FILE PHOTO: A sign marks a Biogen facility in Cambridge
FILE PHOTO: A sign marks a Biogen facility in Cambridge
FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S., March 9, 2020. REUTERS/Brian Snyder
- Advertisment -
Most Read
How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military
November 15, 2024
Palantir shares rally to fresh record on plans for move to Nasdaq
November 15, 2024
EV companies, battery makers urge Trump not to kill vehicle tax credits
November 15, 2024
Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims
November 15, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok
